
Association between vaccination and persistent COVID-19-related symptoms among patients with mild Omicron infection: A prospective cohort study
2024; Elsevier BV; Volume: 21; Linguagem: Inglês
10.1016/j.jvacx.2024.100579
ISSN2590-1362
AutoresMarciane Maria Rover, Fernando Luís Scolari, Geraldine Trott, Mariana Motta Dias da Silva, Denise de Souza, Rosa da Rosa Minho dos Santos, Raíne Fogliati De Carli Schardosim, Emelyn de Souza Roldão, Gabriel Pozza Estivalete, Gabriela Soares Rech, Duane Mocellin, Jennifer Menna Barreto de Souza, Aline Paula Miozzo, Carolina Rothmann Itaqui, Gabrielle Nunes da Silva, Juliana de Mesquita Neto, Hellen Jordan Martins Freitas, Catherine Vitória Pereira dos Santos, Alanys Santos da Silveira, Carla Moura D'Ávila, Christian Morais Soares, João Vítor Gozzi, Ingrid Flor Dos Santos, Sidiclei Machado Carvalho, Vivian Menezes Irineu, Odílson Marcos Silvestre, Kênia do Carmo Marinho Borges, Precil Diego Miranda de Menezes Neves, Fernando Azevedo Medrado, Juliana Carvalho Schleder, Thiago Pelissari Dos Santos, Estêvão Lanna Figueiredo, Benedito Antônio Lopes da Fonseca, Sérgio Luiz Zimmermann, Mauricio Antonio Pompilho, Luciane Maria Facchi, Otávio Gebara, Milena Soriano Marcolino, Ana Carolina Peçanha Antônio, Paulo Roberto Schvartzman, Bruna Brandão Barreto, Caroline Cabral Robinson, Maicon Falavigna, Luiz Antônio Nasi, Carísi Anne Polanczyk, Andréia Biolo, Régis Goulart Rosa,
Tópico(s)COVID-19 and Mental Health
ResumoWhile COVID-19 vaccination has been shown to reduce the risk of severe illness, its impact on the occurrence of persistent symptoms in patients with mild Omicron infection remains uncertain. Our objective was to investigate whether COVID-19 vaccination reduces the occurrence of persistent COVID-19-related symptoms 3 months after mild Omicron infection.
Referência(s)